Loading patent…
AssigneeShanghai University of Traditional Chinese Medicine
InventorsTong ZHANG, Yue DING, Lu LU, Sheng'an ZHANG, Min JIANG, Fulun LI
Estimating the term…
The present disclosure provides use of a timosaponin enzymatically transformed product in preparation of drugs for inhibiting skin superficial fungi. In the use provided in the present disclosure, the timosaponin enzymatically transformed product is prepared by enzymatically transforming rhizoma anemarrhenae extract with β-glucosidase or a compound enzyme of xylanase and cellulose after purification. In the present disclosure, as an active pharmaceutical ingredient for inhibiting skin superficial fungi, the timosaponin enzymatically transformed product has the minimum inhibitory concentration of 4 mg/L against fungi, which is obviously superior to total timosaponin in the bacteriostatic capability, and has a certain application prospect in the aspect of treating skin superficial mycoses.
Use of a timosaponin enzymatically transformed product in preparation of drugs for inhibiting skin superficial fungi, wherein the timosaponin enzymatically transformed product is prepared by enzymatically transforming rhizoma anemarrhenae extract with β-glucosidase to obtain the timosaponin enzymatically transformed product.
Use of a timosaponin enzymatically transformed product containing high-purity timosaponin AIII in preparation of drugs for inhibiting skin superficial fungi, wherein the timosaponin enzymatically transformed product is prepared by:
A drug for inhibiting skin superficial fungi, wherein a raw material of the drug for inhibiting skin superficial fungi comprises timosaponin enzymatically transformed product or timosaponin AIII.
Dependencies are inferred from the claim text.